Note that some links may require registration or subscription. DermaRite Industries is recalling certain lots of its over-the ...

Plus more pharma news from the Pharmalittle newsletter.

It is not clear whether Prasad will still serve as the agency’s chief medical and scientific officer, Stat reports. Meanwhile, Center for Drug Evaluation and Research staff grill top drug regulator ...

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration.

With fall approaching and COVID-19 activity rising across the country, confusion over vaccines is widespread. Mixed messages ...

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency.

I don’t know what we’re supposed to do,” said Aaron Hardwick, who tested positive for COVID-19 in June. “Can we get the shot?

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

Prasad resigned from the FDA in July after backlash over his handling of Sarepta’s Elevidys gene therapy, which faced ...

President Donald Trump announced that he's nominating State Department spokesperson Tammy Bruce to be the next deputy representative of the United States to the United Nations.

T O APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, ...